STOCK TITAN

Callan JMB Inc. Financials

CJMB
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Callan JMB Inc. (CJMB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CJMB FY2025

Callan JMB shifted from cash-rich, high-margin operations to a financing-supported cost structure where overhead overwhelms sales.

Across FY2023-FY2025, gross margin only slipped from 42.8% to 36.8%, but selling and administrative expense expanded as revenue contracted, turning the problem into a cost-base mismatch rather than a collapse in unit economics. In FY2025, financing inflows of $5.2M largely offset operating cash burn of -$4.5M, so liquidity held up even as the core business consumed cash.

Short-term liquidity still looks workable with a current ratio of 2.2x, so the immediate strain is not a near-term payables squeeze. The deeper shift is in the capital structure: debt to equity moved from 0.1x in FY2023 to 1.5x in FY2025 as repeated losses shrank the equity cushion.

Earlier cash generation appears to have been helped by working-capital release, especially as receivables fell from $2.9M to $343K across FY2023-FY2025. Once that cash source thinned out, operating cash flow dropped to -$4.5M in FY2025, making the loss profile look increasingly like a real cash drain rather than an accounting-only setback.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 23 / 100
Financial Health Score 23/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Callan JMB Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
16

Callan JMB Inc. has an operating margin of -122.9%, meaning the company retains $-123 of operating profit per $100 of revenue. This below-average margin results in a low score of 16/100, suggesting thin profitability after operating expenses. This is down from -34.7% the prior year.

Growth
3

Callan JMB Inc.'s revenue declined 12.8% year-over-year, from $6.6M to $5.7M. This contraction results in a growth score of 3/100.

Leverage
37

Callan JMB Inc. has a moderate D/E ratio of 1.48. This balance of debt and equity financing earns a leverage score of 37/100.

Liquidity
62

Callan JMB Inc.'s current ratio of 2.16 indicates adequate short-term liquidity, earning a score of 62/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
10

While Callan JMB Inc. generated -$4.5M in operating cash flow, capex of $617K consumed most of it, leaving -$5.2M in free cash flow. This results in a low score of 10/100, reflecting heavy capital investment rather than weak cash generation.

Returns
12

Callan JMB Inc. generates a -342.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 12/100. This is down from -72.3% the prior year.

Altman Z-Score Distress
-4.43

Callan JMB Inc. scores -4.43, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($4.3M) relative to total liabilities ($3.4M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
1/8

Callan JMB Inc. passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Low Quality
0.57x

For every $1 of reported earnings, Callan JMB Inc. generates $0.57 in operating cash flow (-$4.5M OCF vs -$8.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-2629.7x

Callan JMB Inc. earns $-2629.7 in operating income for every $1 of interest expense (-$7.0M vs $3K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$5.7M
YoY-12.8%

Callan JMB Inc. generated $5.7M in revenue in fiscal year 2025. This represents a decrease of 12.8% from the prior year.

EBITDA
-$6.9M
YoY-223.0%

Callan JMB Inc.'s EBITDA was -$6.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 223.0% from the prior year.

Net Income
-$8.0M
YoY-247.3%

Callan JMB Inc. reported -$8.0M in net income in fiscal year 2025. This represents a decrease of 247.3% from the prior year.

EPS (Diluted)
$-1.82
YoY-109.2%

Callan JMB Inc. earned $-1.82 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 109.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$5.2M
YoY-1144.9%

Callan JMB Inc. generated -$5.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 1144.9% from the prior year.

Cash & Debt
$2.1M
YoY+1.6%

Callan JMB Inc. held $2.1M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
5M
YoY+62.0%

Callan JMB Inc. had 5M shares outstanding in fiscal year 2025. This represents an increase of 62.0% from the prior year.

Margins & Returns

Gross Margin
36.8%
YoY-2.3pp

Callan JMB Inc.'s gross margin was 36.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.3 percentage points from the prior year.

Operating Margin
-122.9%
YoY-88.3pp

Callan JMB Inc.'s operating margin was -122.9% in fiscal year 2025, reflecting core business profitability. This is down 88.3 percentage points from the prior year.

Net Margin
-139.2%
YoY-104.2pp

Callan JMB Inc.'s net profit margin was -139.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 104.2 percentage points from the prior year.

Return on Equity
-342.2%
YoY-269.9pp

Callan JMB Inc.'s ROE was -342.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 269.9 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$617K
YoY+1236.2%

Callan JMB Inc. invested $617K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 1236.2% from the prior year.

CJMB Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $1.1M-4.7% $1.2M-19.8% $1.4M-13.2% $1.7M+15.0% $1.4M+7.2% $1.4M-5.8% $1.4M-27.7% $2.0M
Cost of Revenue $679K-16.1% $809K-15.1% $954K-6.7% $1.0M+22.7% $833K-10.6% $933K-3.9% $971K-5.1% $1.0M
Gross Profit $427K+21.6% $351K-28.8% $493K-23.4% $644K+4.5% $616K+47.0% $419K-9.8% $464K-51.7% $962K
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $2.1M-8.4% $2.3M-2.1% $2.4M+15.9% $2.0M+10.4% $1.9M+9.6% $1.7M+35.9% $1.2M+13.7% $1.1M
Operating Income -$1.7M+32.3% -$2.5M-33.8% -$1.9M-34.0% -$1.4M-13.3% -$1.2M+2.7% -$1.3M-63.0% -$781K-485.3% -$133K
Interest Expense $63 N/A $473 N/A $63+6200.0% $1-99.8% $458-74.6% $2K
Income Tax $306 N/A N/A -$3K-171.1% $4K-82.8% $25K-2.4% $26K+230.0% -$20K
Net Income -$3.2M-23.8% -$2.6M+4.9% -$2.7M-95.4% -$1.4M-12.6% -$1.2M+4.2% -$1.3M-60.9% -$805K-615.7% -$112K
EPS (Diluted) $-0.32 N/A $-0.61-96.8% $-0.31+47.5% $-0.59 N/A $-0.27-575.0% $-0.04

CJMB Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $5.7M-1.1% $5.8M-25.3% $7.7M-13.7% $9.0M+6.0% $8.5M+66.4% $5.1M N/A N/A
Current Assets $3.0M-0.8% $3.1M-28.7% $4.3M-23.2% $5.6M-17.8% $6.8M+104.9% $3.3M N/A N/A
Cash & Equivalents $1.4M-33.6% $2.1M-23.6% $2.8M-34.0% $4.2M-19.1% $5.2M+148.8% $2.1M N/A N/A
Inventory $218K-10.4% $243K+9.0% $223K+13.0% $198K-8.6% $216K+36.4% $158K N/A N/A
Accounts Receivable $824K+139.9% $343K-63.7% $946K+54.0% $614K-26.4% $835K+34.0% $623K N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $4.1M+19.2% $3.4M-3.2% $3.6M+13.4% $3.1M+90.5% $1.6M-13.7% $1.9M N/A N/A
Current Liabilities $1.5M+7.2% $1.4M+18.7% $1.2M-9.2% $1.3M+25.0% $1.0M-17.7% $1.3M N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $1.6M-31.3% $2.3M-44.2% $4.2M-28.3% $5.8M-14.4% $6.8M+114.5% $3.2M-28.1% $4.4M-15.4% $5.2M
Retained Earnings -$13.5M-31.3% -$10.3M-33.8% -$7.7M-55.3% -$4.9M-39.7% -$3.5M-54.1% -$2.3M N/A N/A

CJMB Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$1.7M-154.9% -$659K+62.6% -$1.8M-213.0% -$563K+63.9% -$1.6M-116.0% -$723K-173.2% $988K+267.7% $269K
Capital Expenditures $35K $0-100.0% $169K-60.8% $433K+2783.4% $15K $0-100.0% $293-75.9% $1K
Free Cash Flow -$1.7M-160.3% -$659K+65.9% -$1.9M-94.0% -$996K+36.8% -$1.6M-118.0% -$723K-173.2% $988K+269.3% $267K
Investing Cash Flow -$35K $0+100.0% -$169K+60.8% -$433K-2783.4% -$15K $0+100.0% -$293+75.9% -$1K
Financing Cash Flow $1.0M+99999900.0% $1-100.0% $498K $0-100.0% $4.7M+39668.8% $12K+145.2% -$26K+66.2% -$77K
Dividends Paid N/A N/A N/A N/A N/A -$54K-5399800.0% -$1-200.0% $1
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

CJMB Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 38.6%+8.3pp 30.3%-3.8pp 34.1%-4.6pp 38.6%-3.9pp 42.5%+11.5pp 31.0%-1.4pp 32.4%-16.1pp 48.5%
Operating Margin -153.8%+62.9pp -216.7%-86.8pp -129.9%-45.7pp -84.2%+1.3pp -85.4%+8.7pp -94.2%-39.8pp -54.4%-47.7pp -6.7%
Net Margin -290.6%-66.9pp -223.8%-35.0pp -188.8%-104.9pp -83.9%+1.7pp -85.6%+10.2pp -95.8%-39.7pp -56.1%-50.4pp -5.7%
Return on Equity -201.0%-89.5pp -111.5%-46.1pp -65.4%-41.4pp -24.0%-5.8pp -18.2%+22.6pp -40.8%-22.6pp -18.2%-16.1pp -2.1%
Return on Assets -56.3%-11.3pp -45.0%-9.6pp -35.3%-19.7pp -15.6%-0.9pp -14.7%+10.8pp -25.5% N/A N/A
Current Ratio 2.00-0.2 2.16-1.4 3.60-0.7 4.26-2.2 6.49+3.9 2.60 N/A N/A
Debt-to-Equity 2.57+1.1 1.48+0.6 0.85+0.3 0.54+0.3 0.24-0.4 0.60 N/A N/A
FCF Margin -155.1%-98.3pp -56.8%+76.8pp -133.5%-73.8pp -59.8%+49.0pp -108.8%-55.3pp -53.5%-122.3pp 68.8%+55.3pp 13.5%

Similar Companies

Frequently Asked Questions

Callan JMB Inc. (CJMB) reported $5.7M in total revenue for fiscal year 2025. This represents a -12.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Callan JMB Inc. (CJMB) revenue declined by 12.8% year-over-year, from $6.6M to $5.7M in fiscal year 2025.

No, Callan JMB Inc. (CJMB) reported a net income of -$8.0M in fiscal year 2025, with a net profit margin of -139.2%.

Callan JMB Inc. (CJMB) reported diluted earnings per share of $-1.82 for fiscal year 2025. This represents a -109.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Callan JMB Inc. (CJMB) had EBITDA of -$6.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Callan JMB Inc. (CJMB) had a gross margin of 36.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Callan JMB Inc. (CJMB) had an operating margin of -122.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Callan JMB Inc. (CJMB) had a net profit margin of -139.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Callan JMB Inc. (CJMB) has a return on equity of -342.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Callan JMB Inc. (CJMB) generated -$5.2M in free cash flow during fiscal year 2025. This represents a -1144.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Callan JMB Inc. (CJMB) generated -$4.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Callan JMB Inc. (CJMB) had $5.8M in total assets as of fiscal year 2025, including both current and long-term assets.

Callan JMB Inc. (CJMB) invested $617K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Callan JMB Inc. (CJMB) had 5M shares outstanding as of fiscal year 2025.

Callan JMB Inc. (CJMB) had a current ratio of 2.16 as of fiscal year 2025, which is generally considered healthy.

Callan JMB Inc. (CJMB) had a debt-to-equity ratio of 1.48 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Callan JMB Inc. (CJMB) had a return on assets of -137.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Callan JMB Inc. (CJMB) had $2.1M in cash against an annual operating cash burn of $4.5M. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Callan JMB Inc. (CJMB) has an Altman Z-Score of -4.43, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Callan JMB Inc. (CJMB) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Callan JMB Inc. (CJMB) has an earnings quality ratio of 0.57x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Callan JMB Inc. (CJMB) has an interest coverage ratio of -2629.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Callan JMB Inc. (CJMB) scores 23 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top